Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als symbols : Crnx save search
Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer
Published: 2022-03-21 (Crawled : 12:00) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 1.76%
H: 0.0%
C: -3.5%
als
Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors
Published: 2022-03-14 (Crawled : 10:00) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: -2.12%
H: 0.0%
C: 0.0%
als
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-10 (Crawled : 23:00) - globenewswire.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 1.5%
H: 0.0%
C: 0.0%
als nasdaq grant granted
Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer
Published: 2022-03-01 (Crawled : 12:00) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 2.12%
H: 2.89%
C: -0.81%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: -0.3%
H: 1.46%
C: -1.63%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: 1.56%
H: 3.9%
C: 1.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
als commercialization
Crinetics Pharmaceuticals and Sanwa Kagaku Kenkyusho Enter into Exclusive Licensing Agreement for the Development and Commercialization of Paltusotine in Japan
Published: 2022-02-28 (Crawled : 11:00) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
als commercialization license
Crinetics Pharmaceuticals to Participate in SVB Leerink Global Healthcare Conference
Published: 2022-02-09 (Crawled : 12:30) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 3.09%
H: 3.65%
C: 2.02%
health als thc conference svb leerink global
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-02-01 (Crawled : 22:00) - crinetics.com
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: 0.53%
H: 4.67%
C: -5.6%
als nasdaq grant granted
Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of Rogério Vivaldi Coelho, M.D., M.B.A.
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: -0.57%
H: 1.86%
C: -2.46%
als disease rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.